Evidence mapPaperPMID 41504385Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2026

ERA's ABCDE framework for kidney disease prevention: turning the WHO kidney health resolution into action.

European Renal Association (ERA) Council:, Roser Torra, Dimitrios S Goumenos, Mustafa Arici, Alberto Ortiz, Marcin Adamczak, Kathrin Eller, Ana Carina Ferreira, Giuseppe Grandaliano, Kitty Jager and 8 more

Abstract readConsensus Statement
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

European Renal Association (ERA) Council:
Roser Torra
Dimitrios S Goumenos
Mustafa Arici
Alberto Ortiz
Marcin Adamczak
Kathrin Eller
Ana Carina Ferreira
Giuseppe Grandaliano
Kitty Jager
Jennifer Lees
Vassilios Liakopoulos
Roberto Minutolo
Siren Sezer
ERA Senior Staff:
Federico Torres
Laura Azzolini
Monica Fontana

Funding

Comunidad de Madrid en Biomedicina P2022/BMD-7223COST CA21165EU4H 101101220EU4H 101137054EU4H 101168626European Union PMP21/00109FEDERInstituto de Salud Carlos III RD21/0005/0001Instituto de Salud Carlos III RD24/0004/0001
6 · The paper itself

Abstract

In 2025, the World Health Assembly of the World Health Organization (WHO) adopted a resolution on reducing the burden of noncommunicable diseases (NCDs) by promoting kidney health and strengthening the prevention and control of kidney disease. Following the WHO resolution, the United Nations (UN) included kidney health in its 2025 Political Declaration on NCDs. These measures are a clear response to the growing burden of kidney diseases. This achievement for kidney health was facilitated by years of effort by multiple stakeholders and decision-makers, including nephrology associations, particularly the International Society of Nephrology, the European Renal Association (ERA) and the American Society of Nephrology, gathering evidence on the growing burden of chronic kidney disease (CKD), raising awareness of this burden, advancing research and innovation, and adopting scientific and policy recommendations for the early detection, prevention and treatment of CKD. The WHO and UN measures add kidney disease to a list of major NCDs (e.g. cancer, cardiovascular diseases, diabetes, respiratory diseases) that should be prioritized by healthcare systems. The kidney health resolution is fully aligned with the ERA's activities and recommendations, as well as with the 2025 KDIGO document on the prevention of CKD and maintenance of kidney health. This novel preventive approach has been tried and tested for other conditions, such as cardiovascular disease, the age-adjusted mortality of which is falling dramatically, compared with the equally dramatic increase in CKD mortality. The next step would be to define an actionable condition of very high risk of CKD, that may be termed pre-CKD. This should be complemented by programs for the early diagnosis and treatment of CKD, such as the one promoted by ERA's 'Protect Your Kidneys, Protect Your Future' campaign which emphasizes the need to know and treat the ABCDE numbers (Albuminuria, Blood pressure, Cholesterol, Diabetes, Estimated glomerular filtration rate) to improve cardiovascular-kidney-metabolic health.

Indexed as

Kidney DiseasesRenal Insufficiency, ChronicWorld Health OrganizationGlobal HealthHumansalbuminuriachronic kidney diseasepre-CKDprevention of CKD

Identifiers

PMID41504385
PMCPMC13037474

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.